Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation

  • A simulation study has been performed to quantify the effect of volume reduction on the thyroid absorbed dose per decay and to investigate the variation of energy deposition per decay due to β-and γ-activity of 131I with volume/mass of thyroid, for water, ICRP-and ICRU-soft tissue taken as thyroid material. A Monte Carlo model of the thyroid, in the Geant4 radiation transport simulation toolkit was constructed to compute the β-and γ-absorbed dose in the simulated thyroid phantom for various values of its volume. The effect of the size and shape of the thyroid on energy deposition per decay has also been studied by using spherical, ellipsoidal and cylindrical models for the thyroid and varying its volume in 1—25 cm3 range. The relative differences of Geant4 results for different models with each other and MCNP results lie well below 1.870%. The maximum relative difference among the Geant4 estimated results for water with ICRP and ICRU soft tissues is not more than 0.225%. S-values for ellipsoidal, spherical and cylindrical thyroid models were estimated and the relative difference with published results lies within 3.095%. The absorbed fraction values for beta particles show a good agreement with published values within 2.105% deviation. The Geant4 based simulation results of absorbed fractions for gammas again show a good agreement with the corresponding MCNP and EGS4 results (± 6.667%) but have 29.032% higher values than that of MIRD calculated values. Consistent with previous studies, the reduction of the thyroid volume is found to have a substantial effect on the absorbed dose. Geant4 simulations confirm dose dependence on the volume/mass of thyroid in agreement with MCNP and EGS4 computed values but are substantially different from MIRD8 data. Therefore, inclusion of size/mass dependence is indicated for 131I radiotherapy of the thyroid.
      PCAS:
  • 加载中
  • [1] Lassmann M et al. Endicrine-Related Cancer, 2010, 17: R161-R172[2] Haugen B R. Seminars in Surgical Oncology, 1999, 16: 34-41[3] Jentzen W et al. European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37: 884-895[4] Clarke S E M. Clinical Oncology, 2010, 22: 430-437[5] Freudenberg M W R, Kotzerke J. Z. Med. Phys., 2011, 21: 9[6] Tuttle R M et al. Journal of Nuclear Medicine, 2006, 47: 1587-1591[7] Haq M S et al. Nuclear Medicine Communications, 2004, 25: 799-805[8] Stabin M G, Flux G D. Biomedical Imaging Intervention Journal, 2007, 3: e28[9] Barca F C G, Chauvie S, Cuce D. Nuclear Physics B, 2003, 125: 5[10] Meo S L et al. Nuclear Medicine Communications, 2008, 29: 1100-1105[11] Mowlavi A A et al. Radiology and Oncology, 2011, 45: 143-146[12] Siegel J A, Stabin M G. Journal of Nuclear Medicine, 1994, 35: 152-156[13] Berger M J. Journal of Nuclear Medicine, 1971, 12: 5-23[14] Stabin M G, Konijinenberg M W. Journal of Nuclear Medicine, 2000, 41: 149-160[15] Bogazzi F et al. Journal of Clinical Endocrinology Metabolism, 1999, 84: 499-503[16] Chiovato L et al. Journal of Clinical Endocrinology Metabolism, 1998, 25: 40-46[17] Peters H et al. Euorpean Journal of Clinical Investigation, 1996, 26: 59-63[18] Traino A C et al. Physics in Medicine and Biology, 2000, 45: 121-129[19] Grosev D et al. Nuklearmedizin, 2008, 47: 120-126[20] Agostinelli S et al. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 2003, 506: 250-303[21] Allison J et al. IEEE Transactions on Nuclear Science, 2006, 53: 270-278[22] Brownell G L et al. Journal of Nuclear Medicine, 1968, 9: 27-39[23] Cember H. Introduction to Health Physics: McGraw-Hill, Health Professions Division, 1996[24] Kadri O et al. Applied Radiation and Isotopes, 2006, 64: 170-177[25] Ellen W H, Humes R M. MIRD Pamphlet 8, Journal of Nuclear Medicine, 1971, 12: 25-32[26] Stabin M G. Journal of Nuclear Medicine, 1996, 37: 538-546
  • 加载中

Get Citation
Ziaur Rahman, Sikander M, Waheed Arshed, Nasir M and Waheed Ahmed. Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation[J]. Chinese Physics C, 2014, 38(5): 056201. doi: 10.1088/1674-1137/38/5/056201
Ziaur Rahman, Sikander M, Waheed Arshed, Nasir M and Waheed Ahmed. Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation[J]. Chinese Physics C, 2014, 38(5): 056201.  doi: 10.1088/1674-1137/38/5/056201 shu
Milestone
Received: 2013-06-19
Revised: 1900-01-01
Article Metric

Article Views(1212)
PDF Downloads(158)
Cited by(0)
Policy on re-use
To reuse of subscription content published by CPC, the users need to request permission from CPC, unless the content was published under an Open Access license which automatically permits that type of reuse.
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Email This Article

Title:
Email:

Influence of thyroid volume reduction on absorbed dose in 131I therapy studied by using Geant4 Monte Carlo simulation

Abstract: A simulation study has been performed to quantify the effect of volume reduction on the thyroid absorbed dose per decay and to investigate the variation of energy deposition per decay due to β-and γ-activity of 131I with volume/mass of thyroid, for water, ICRP-and ICRU-soft tissue taken as thyroid material. A Monte Carlo model of the thyroid, in the Geant4 radiation transport simulation toolkit was constructed to compute the β-and γ-absorbed dose in the simulated thyroid phantom for various values of its volume. The effect of the size and shape of the thyroid on energy deposition per decay has also been studied by using spherical, ellipsoidal and cylindrical models for the thyroid and varying its volume in 1—25 cm3 range. The relative differences of Geant4 results for different models with each other and MCNP results lie well below 1.870%. The maximum relative difference among the Geant4 estimated results for water with ICRP and ICRU soft tissues is not more than 0.225%. S-values for ellipsoidal, spherical and cylindrical thyroid models were estimated and the relative difference with published results lies within 3.095%. The absorbed fraction values for beta particles show a good agreement with published values within 2.105% deviation. The Geant4 based simulation results of absorbed fractions for gammas again show a good agreement with the corresponding MCNP and EGS4 results (± 6.667%) but have 29.032% higher values than that of MIRD calculated values. Consistent with previous studies, the reduction of the thyroid volume is found to have a substantial effect on the absorbed dose. Geant4 simulations confirm dose dependence on the volume/mass of thyroid in agreement with MCNP and EGS4 computed values but are substantially different from MIRD8 data. Therefore, inclusion of size/mass dependence is indicated for 131I radiotherapy of the thyroid.

    HTML

Reference (1)

目录

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return